{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:03:44Z","timestamp":1791147824035,"version":"4.1.0"},"reference-count":48,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In mucopolysaccharidosis-I (MPS-I), \u03b1-L-iduronidase deficiency leads to progressive heparan sulfate (HS) and dermatan sulfate (DS) glycosaminoglycan (GAG) accumulation. The functional consequences of these accumulated molecules are unknown. HS critically influences tissue morphogenesis by binding to and modulating the activity of several cytokines (eg, fibroblast growth factors [FGFs]) involved in developmental patterning. We recently isolated a multipotent progenitor cell from postnatal human bone marrow, which differentiates into cells of all 3 embryonic lineages. The availability of multipotent progenitor cells from healthy volunteers and patients with MPS-I (Hurler syndrome) provides a unique opportunity to directly examine the functional effects of abnormal HS on cytokine-mediated stem-cell proliferation and survival. We demonstrate here that abnormally sulfated HS in Hurler multipotent progenitor cells perturb critical FGF-2\u2013FGFR1-HS interactions, resulting in defective FGF-2\u2013induced proliferation and survival of Hurler multipotent progenitor cells. Both the mitogenic and survival-promoting activities of FGF-2 were restored by substitution of Hurler HS by normal HS. This perturbation of critical HS\u2013cytokine receptor interactions may represent a mechanism by which accumulated HS contributes to the developmental pathophysiology of Hurler syndrome. Similar mechanisms may operate in the pathogenesis of other diseases where structurally abnormal GAGs accumulate.<\/jats:p>","DOI":"10.1182\/blood-2005-02-0657","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T00:34:33Z","timestamp":1118363673000},"page":"1956-1964","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":58,"title":["Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells"],"prefix":"10.1182","volume":"106","author":[{"given":"Chendong","family":"Pan","sequence":"first","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Nelson","sequence":"additional","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morayma","family":"Reyes","sequence":"additional","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Koodie","sequence":"additional","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Brazil","sequence":"additional","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot J.","family":"Stephenson","sequence":"additional","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Zhao","sequence":"additional","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Peters","sequence":"additional","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Selleck","sequence":"additional","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally E.","family":"Stringer","sequence":"additional","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Gupta","sequence":"additional","affiliation":[{"name":"From the Hematology\/Oncology Section, Veterans Affairs Medical Center; the Stem Cell Institute, the Pediatric Hematology-Oncology and Blood and Marrow Transplantation Program, the Department of Genetics, Cell Biology and Development, the Department of Pediatrics, and the Hematology-Oncology-Transplantation Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN; and the Chinese Academy of Medical Sciences and State Key Laboratory of Experimental Hematology, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218334949300_REF1","unstructured":"Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular basis of Inherited Disease. Vol III. New York, NY: McGraw-Hill; 2001: 3421-3452."},{"key":"2020021218334949300_REF2","doi-asserted-by":"crossref","unstructured":"Russell C, Hendson G, Jevon G, et al. Murine MPS I: insights into the pathogenesis of Hurler syndrome. Clin Genet. 1998;53: 349-361.","DOI":"10.1111\/j.1399-0004.1998.tb02745.x"},{"key":"2020021218334949300_REF3","unstructured":"Whitley CB. The mucopolysaccharidoses. In: Moser HW, ed. Neurodystrophies and Neurolipidoses. Vol 66 (22). Elsevier Science; 1996: 281-328."},{"key":"2020021218334949300_REF4","unstructured":"Lyon G, Adams RD, Kolodny EH. Late infantile progressive genetic encephalopathies: neurology of hereditary metabolic diseases of children (Second Ed). New York, NY: McGraw Hill; 1996: 124-176."},{"key":"2020021218334949300_REF5","doi-asserted-by":"crossref","unstructured":"Conrad HE. Fibroblast growth factors. Heparin binding proteins. San Diego, CA: Academic Press; 1998: 301-349.","DOI":"10.1016\/B978-012186060-8\/50010-3"},{"key":"2020021218334949300_REF6","doi-asserted-by":"crossref","unstructured":"Vaccarino FM, Schwartz ML, Raballo R, Rhee J, Lyn-Cook R. Fibroblast growth factor signaling regulates growth and morphogenesis at multiple steps during brain development. Curr Top Dev Biol. 1999;46: 179-200.","DOI":"10.1016\/S0070-2153(08)60329-4"},{"key":"2020021218334949300_REF7","doi-asserted-by":"crossref","unstructured":"Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 1991;64: 841-848.","DOI":"10.1016\/0092-8674(91)90512-W"},{"key":"2020021218334949300_REF8","doi-asserted-by":"crossref","unstructured":"Chang Z, Meyer K, Rapraeger AC, Friedl A. Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J. 2000;14: 137-144.","DOI":"10.1096\/fasebj.14.1.137"},{"key":"2020021218334949300_REF9","doi-asserted-by":"crossref","unstructured":"Krufka A, Guimond S, Rapraeger AC. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding\/receptor transphosphorylation. Biochemistry. 1996;35: 11131-11141.","DOI":"10.1021\/bi960125+"},{"key":"2020021218334949300_REF10","doi-asserted-by":"crossref","unstructured":"Bernfield M, Gotte M, Park PY, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 1999;68: 729-777.","DOI":"10.1146\/annurev.biochem.68.1.729"},{"key":"2020021218334949300_REF11","unstructured":"Gallagher JT, Lyon M. Heparan sulfate: molecular structure and interactions with growth factors and morphogens. In: Iozzo RV, ed. Proteoglycans. New York, NY: Marcel Dekker, Inc; 2000: 27-60."},{"key":"2020021218334949300_REF12","doi-asserted-by":"crossref","unstructured":"Perrimon N, Bernfield M. Specificities of heparan sulphate proteoglycans in developmental processes. Nature. 2000;404: 725-728.","DOI":"10.1038\/35008000"},{"key":"2020021218334949300_REF13","doi-asserted-by":"crossref","unstructured":"Pye DA, Vives RR, Hyde P, Gallagher JT. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2. Glycobiology. 2000;10: 1183-1192.","DOI":"10.1093\/glycob\/10.11.1183"},{"key":"2020021218334949300_REF14","doi-asserted-by":"crossref","unstructured":"Yamaguchi Y. Heparan sulfate proteoglycans in the nervous system: their diverse roles in neurogenesis, axon guidance, and synaptogenesis. Semin Cell Dev Biol. 2001;12: 99-106.","DOI":"10.1006\/scdb.2000.0238"},{"key":"2020021218334949300_REF15","doi-asserted-by":"crossref","unstructured":"Alzheimer C, Werner S. Fibroblast growth factors and neuroprotection. Adv Exp Med Biol. 2002; 513: 335-351.","DOI":"10.1007\/978-1-4615-0123-7_12"},{"key":"2020021218334949300_REF16","doi-asserted-by":"crossref","unstructured":"Matalon R, Dorfman A. The structure of acid mucopolysaccharides produced by Hurler fibroblasts in tissue culture. Proc Natl Acad Sci U S A. 1968; 60: 179-185.","DOI":"10.1073\/pnas.60.1.179"},{"key":"2020021218334949300_REF17","doi-asserted-by":"crossref","unstructured":"Byers S, Rozaklis T, Brumfield LK, Ranieri E, Hopwood JJ. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Mol Genet Metab. 1998;65: 282-290.","DOI":"10.1006\/mgme.1998.2761"},{"key":"2020021218334949300_REF18","doi-asserted-by":"crossref","unstructured":"Knecht J, Cifonelli JA, Dorfman A. Structural studies on heparitin sulfate of normal and Hurler tissues. J Biol Chem. 1967;242: 4652-4661.","DOI":"10.1016\/S0021-9258(18)99507-4"},{"key":"2020021218334949300_REF19","doi-asserted-by":"crossref","unstructured":"Knecht J, Dorfman A. Structure of heparitin sulfate in tissues of the Hurler syndrome. Biochem Biophys Res Commun. 1965;21: 509-515.","DOI":"10.1016\/0006-291X(65)90413-4"},{"key":"2020021218334949300_REF20","doi-asserted-by":"crossref","unstructured":"Gupta P, McCarthy JB, Verfaillie CM. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood. 1996;87: 3229-3236.","DOI":"10.1182\/blood.V87.8.3229.bloodjournal8783229"},{"key":"2020021218334949300_REF21","doi-asserted-by":"crossref","unstructured":"Gupta P, Oegema TR, Brazil JJ, Dudek AZ, Slungaard A, Verfaillie CM. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood. 1998;92: 4641-4651.","DOI":"10.1182\/blood.V92.12.4641"},{"key":"2020021218334949300_REF22","doi-asserted-by":"crossref","unstructured":"Gupta P, Oegema TR, Brazil JJ, Dudek AZ, Slungaard A, Verfaillie CM. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood. 2000;95: 147-155.","DOI":"10.1182\/blood.V95.1.147"},{"key":"2020021218334949300_REF23","doi-asserted-by":"crossref","unstructured":"Peters C, Balthazor M, Shapiro EG, et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood. 1996;87: 4894-4902.","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894"},{"key":"2020021218334949300_REF24","doi-asserted-by":"crossref","unstructured":"Peters C, Shapiro EG, Anderson J, et al. Hurler syndrome, II: outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood. 1998;91: 2601-2608.","DOI":"10.1182\/blood.V91.7.2601"},{"key":"2020021218334949300_REF25","doi-asserted-by":"crossref","unstructured":"Staba SL, Escolar ML, Poe M, et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med. 2004;350: 1960-1969.","DOI":"10.1056\/NEJMoa032613"},{"key":"2020021218334949300_REF26","doi-asserted-by":"crossref","unstructured":"Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98: 2615-2625.","DOI":"10.1182\/blood.V98.9.2615"},{"key":"2020021218334949300_REF27","doi-asserted-by":"crossref","unstructured":"Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418: 41-49.","DOI":"10.1038\/nature00870"},{"key":"2020021218334949300_REF28","doi-asserted-by":"crossref","unstructured":"Keene CD, Ortiz-Gonzalez XR, Jiang Y, Largaespada DA, Verfaillie CM, Low WC. Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant. 2003;12: 201-213.","DOI":"10.3727\/000000003108746768"},{"key":"2020021218334949300_REF29","doi-asserted-by":"crossref","unstructured":"Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002;109: 337-346.","DOI":"10.1172\/JCI0214327"},{"key":"2020021218334949300_REF30","doi-asserted-by":"crossref","unstructured":"Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest. 2002;109: 1291-1302.","DOI":"10.1172\/JCI0215182"},{"key":"2020021218334949300_REF31","doi-asserted-by":"crossref","unstructured":"Jiang Y, Henderson D, Blackstad M, Chen A, Miller RF, Verfaillie CM. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc Natl Acad Sci USA. 2003;100: 11854-11860.","DOI":"10.1073\/pnas.1834196100"},{"key":"2020021218334949300_REF32","doi-asserted-by":"crossref","unstructured":"Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002;30: 215-222.","DOI":"10.1038\/sj.bmt.1703650"},{"key":"2020021218334949300_REF33","doi-asserted-by":"crossref","unstructured":"Bunge S, Clements PR, Byers S, Kleijer WJ, Brooks DA, Hopwood JJ. Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies. Biochim Biophys Acta. 1998;1407: 249-256.","DOI":"10.1016\/S0925-4439(98)00046-5"},{"key":"2020021218334949300_REF34","doi-asserted-by":"crossref","unstructured":"Wasteson A. A method for the determination of the molecular weight and molecular weight distribution of chondroitin sulfate. J Chromatogr. 1971; 59: 87-97.","DOI":"10.1016\/S0021-9673(01)80009-1"},{"key":"2020021218334949300_REF35","doi-asserted-by":"crossref","unstructured":"Toyoda H, Kinoshita-Toyoda A, Selleck SB. Structural analysis of glycosaminoglycans in Drosophila and Caenorhabditis elegans and demonstration that tout-velu, a Drosophila gene related to EXT tumor suppressors, affects heparan sulfate in vivo. J Biol Chem. 2000;275: 2269-2275.","DOI":"10.1074\/jbc.275.4.2269"},{"key":"2020021218334949300_REF36","doi-asserted-by":"crossref","unstructured":"Spivak-Kroizman T, Lemmon MA, Dikic I, et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell. 1994; 79: 1015-1024.","DOI":"10.1016\/0092-8674(94)90032-9"},{"key":"2020021218334949300_REF37","doi-asserted-by":"crossref","unstructured":"Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol. 1992;12: 240-247.","DOI":"10.1128\/MCB.12.1.240"},{"key":"2020021218334949300_REF38","doi-asserted-by":"crossref","unstructured":"Constantopoulos G. Hunter-Hurler syndrome: gel filtration and dialysis of urinary acid mucopolysaccharides. Nature. 1968;220: 583-585.","DOI":"10.1038\/220583b0"},{"key":"2020021218334949300_REF39","doi-asserted-by":"crossref","unstructured":"Constantopoulos G, Iqbal K, Dekaban AS. Mucopolysaccharidosis types IH, IS, II, and IIIA: glycosaminoglycans and lipids of isolated brain cells and other fractions from autopsied tissues. J Neurochem. 1980;34: 1399-1411.","DOI":"10.1111\/j.1471-4159.1980.tb11220.x"},{"key":"2020021218334949300_REF40","doi-asserted-by":"crossref","unstructured":"Dekaban AS, Constantopoulos G. Mucopolysaccharidosis type I, II, IIIA and V: pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain. Acta Neuropathol (Berl). 1977;39: 1-7.","DOI":"10.1007\/BF00690379"},{"key":"2020021218334949300_REF41","doi-asserted-by":"crossref","unstructured":"Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC. Activating and inhibitory heparin sequences for FGF-2 (basic FGF): distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem. 1993;268: 23906-23914.","DOI":"10.1016\/S0021-9258(20)80471-2"},{"key":"2020021218334949300_REF42","doi-asserted-by":"crossref","unstructured":"Pye DA, Vives RR, Turnbull JE, Hyde P, Gallagher JT. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem. 1998;273: 22936-22942.","DOI":"10.1074\/jbc.273.36.22936"},{"key":"2020021218334949300_REF43","unstructured":"Constantopoulos G, Dekaban AS. Content and distribution of molecular weights of mucopolysaccharides in the brain and other organs of Hurler's patients. J Neuropathol Exp Neurol. 1971;30: 144-145."},{"key":"2020021218334949300_REF44","doi-asserted-by":"crossref","unstructured":"Constantopoulos G, Dekaban AS. Neurochemistry of the mucopolysaccharidoses: brain lipids and lysosomal enzymes in patients with four types of mucopolysaccharidosis and in normal controls. J Neurochem. 1978;30: 965-973.","DOI":"10.1111\/j.1471-4159.1978.tb12388.x"},{"key":"2020021218334949300_REF45","doi-asserted-by":"crossref","unstructured":"Constantopoulos G, McComb RD, Dekaban AS. Neurochemistry of the mucopolysaccharidoses: brain glycosaminoglycans in normals and four types of mucopolysaccharidoses. J Neurochem. 1976;26: 901-908.","DOI":"10.1111\/j.1471-4159.1976.tb06471.x"},{"key":"2020021218334949300_REF46","unstructured":"Dekaban AS, Constantopoulos G, Herman MM, Steusing JK. Mucopolysaccharidosis type V (Scheie syndrome): a postmortem study by multidisciplinary techniques with emphasis on the brain. Arch Pathol Lab Med. 1976;100: 237-245."},{"key":"2020021218334949300_REF47","doi-asserted-by":"crossref","unstructured":"Gritti A, Parati EA, Cova L, et al. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci. 1996;16: 1091-1100.","DOI":"10.1523\/JNEUROSCI.16-03-01091.1996"},{"key":"2020021218334949300_REF48","doi-asserted-by":"crossref","unstructured":"Li HH, Zhao HZ, Neufeld EF, Cai Y, Gomez-Pinilla F. Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B. J Neurosci Res. 2002;69: 30-38.","DOI":"10.1002\/jnr.10278"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/6\/1956\/1635015\/zh801805001956.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/6\/1956\/1635015\/zh801805001956.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T14:31:50Z","timestamp":1626013910000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/6\/1956\/21635\/Functional-abnormalities-of-heparan-sulfate-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,15]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,9,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-02-0657","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,15]]}}}